Glenmede Investment Management, LP Takeda Pharmaceutical CO LTD Transaction History
Glenmede Investment Management, LP
- $20 Billion
- Q3 2025
A detailed history of Glenmede Investment Management, LP transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Glenmede Investment Management, LP holds 34,677 shares of TAK stock, worth $495,534. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,677
Previous 30,853
12.39%
Holding current value
$495,534
Previous $477 Million
99.89%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TAK
# of Institutions
385Shares Held
80.6MCall Options Held
1.7MPut Options Held
276K-
Capital Research Global Investors Los Angeles, CA13.4MShares$192 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.69MShares$110 Million0.01% of portfolio
-
Ubs Group Ag5.89MShares$84.2 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.95MShares$70.8 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.93MShares$56.2 Million0.48% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $44.4B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...